tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Balaji Prasad, 23 are a SELL (11.62%), 18 are a HOLD (9.09%), 157 are a BUY (79.29%).
Analyst Balaji Prasad, currently employed at BARCLAYS, carries an average stock price target met ratio of 46.06% that have a potential upside of 24.25% achieved within 237 days.
Balaji Prasad’s has documented 405 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EOLS, Evolus at 05-Mar-2025.
Analyst best performing recommendations are on MNK (MALLINCKRODT PLC).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $123.52 was fulfilled within 1 day with a profit of $11.16 (9.93%) receiving and performance score of 99.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$10
$5.33 (114.13%)
$10
17 days ago
(02-May-2025)
12/25 (48%)
$4.58 (84.50%)
252
Buy
$10
$5.33 (114.13%)
$14
8 months ago
(19-Sep-2024)
0/3 (0%)
$1.82 (22.25%)
Sell
$3
$-1.67 (-35.76%)
$9
9 months 17 days ago
(02-Aug-2024)
11/14 (78.57%)
$-2.63 (-46.71%)
201
Hold
$7
$2.33 (49.89%)
9 months 24 days ago
(25-Jul-2024)
1/1 (100%)
$1.12 (19.05%)
53
Buy
$16
$11.33 (242.61%)
$9.5
1 years 7 months 29 days ago
(20-Sep-2023)
4/5 (80%)
$7.66 (91.85%)
143
Which stock is Balaji Prasad is most bullish on?
Which stock is Balaji Prasad is most reserved on?
What Year was the first public recommendation made by Balaji Prasad?
